Study Exclusion reasons Remarks Reference(s)
COMMIT, 2022 randomized controlled trial inadequate or absent control group Phase 3 Number of pts targettted: 211

Lima C. ASCO June 2022 10.1200/JCO.2022.40.16_suppl.TPS3647

  

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons